Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400202 · ClinicalTrials.gov registry record
Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 44
- Enrollment target
NCT03400202: Completed study, sponsored by Allergan.
NCT03400202 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03400202 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This study will evaluate the physiopathologic characteristics of dark circles in participants with various ethnicities and Fitzpatrick Skin Types and the impact of the dark circles on the quality of life.
Primary Outcome
The investigator will access the participant's lower and upper eyelids using the Dark Circles Severity Scale where 0=None to 9=Severe (very dark circles).
Interventions
- DEVICE Skin imaging
- OTHER Facial cleanser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-02-02 |
| Est. Completion | 2018-11-07 |
What the finished NCT03400202 record still lists
NCT03400202 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Skin imaging is the first listed.
NCT03400202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03400202 about?
NCT03400202 is a clinical study titled "Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles". This study will evaluate the physiopathologic characteristics of dark circles in participants with various ethnicities and Fitzpatrick Skin Types and the impact of the dark circles on the quality of life.
What is the current status of trial NCT03400202?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2018-02-02. Estimated completion is 2018-11-07.
What interventions are being tested in trial NCT03400202?
The interventions under investigation include: Skin imaging (DEVICE), Facial cleanser (OTHER).
Who is sponsoring clinical trial NCT03400202?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI